Steven Sanislo, MD
Enriched profileClinical Professor, Ophthalmology · Stanford University School of Medicine
Steven Sanislo is Clinical Professor, Ophthalmology at Stanford University School of Medicine. ClinicalTrials.gov lists 2 registered studies with this person as an investigator.
Data verified 17 Oct 2026
Overview
Updated 31 Oct 2026
Steven Sanislo, MD, is Clinical Professor, Ophthalmology at Stanford University School of Medicine (Stanford Byers Eye Institute). The public record shows 38 publications with 893 citations (h-index 16), centered on Macular Degeneration (AMD), Retinal Drusen. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 8 companies.
- Top research focus: Macular Degeneration (AMD)
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 8 companies
Generated from the cited public record · current as of 31 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →
Clinical trials
Updated 31 Oct 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- Non-Damaging Photothermal Therapy of Non-exudative Age Related Macular Degeneration
Sponsor: Stanford University
- Lucentis in Advanced Macular Degeneration
Sponsor: Steven R. Sanislo
Industry payments
Updated 31 Oct 2026
8 companies reported payments to CMS in program years 2022–2025. These are public disclosures, not judgments. The latest:
- Genentech USA, Inc.Program year20255 payments
- Alcon Vision LLCProgram year20251 payment
- Regeneron Pharmaceuticals, Inc.Program year20241 payment
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Prevalence of Systemic Comorbidities and Ocular Complications in Patients With Bilateral Retinal Telangiectasia
Journal of VitreoRetinal Diseases
2026 - In-Office Vitreous Biopsy With a Vitreous Cutter and Manual Actuation
Ophthalmic surgery, lasers & imaging retina
2024 - Intraoperative Complications With Vitreous Biopsy for Molecular Proteomics
Ophthalmic surgery, lasers & imaging retina
2023 - Visual acuity and progression of macular atrophy in patients receiving intravitreal anti-VEGF for age-related macular degeneration
European Journal of Ophthalmology
2021
Background & recognition
Updated 31 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
- Board certified
American Board of Ophthalmology (Ophthalmology)
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
Secondary affiliations
appointments beyond the home institution- California Vitreoretinal Center
Menlo Park, CA
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →stanfordchildrens.org ↗ - verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Glenn Chertow, MD
Stanford University School of Medicine
Paul Heidenreich, MD
Stanford University School of Medicine
Alan Schatzberg, MD
Stanford University School of Medicine
Maximilian Diehn, MD
Stanford University School of Medicine
Emily Chew, MD
National Eye Institute
Robert Weinreb, MD
University of California San Diego
Harry Quigley, MD
Johns Hopkins University School of Medicine
Joel Schuman, MD
Wills Eye Hospital